Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants
Coronary Artery Disease (CAD)
About this trial
This is an observational trial for Coronary Artery Disease (CAD) focused on measuring Cardiac Rehabilitation, Apoptosis, Gene Expression, Nitric Oxide, Reactive Oxygen Species, Coronary Artery Disease, CAD
Eligibility Criteria
INCLUSION CRITERIA: Adults older than 21 years. Coronary artery disease established by angiography. At least two months interval since myocardial infarction or coronary artery bypass surgery. At least one month interval since percutaneous coronary intervention or congestive heart failure symptoms. No medical condition that might prohibit safe participation in cardiac rehabilitation. Subject understands protocol and provides written, informed consent in addition to willingness to comply with specified follow-up evaluations. EXCLUSION CRITERIA: Significant structural heart disease (e.g. hypertrophic or dilated cardiomyopathy, valvular heart disease) as determined by echocardiography. Angina pectoris that is prolonged in duration (greater than 20 minutes), or does not respond to nitroglycerin (2 tablets) within 2 weeks of referral to the program. Subjects physically unable to perform cardiac rehabilitation protocol due to neurologic or orthopedic conditions. Women of childbearing age unless recent pregnancy test is negative. Lactating women. Implantable cardioverter-defibrillator (ICD)
Sites / Locations
- Suburban Hospital
- National Institutes of Health Clinical Center, 9000 Rockville Pike